APA (7th ed.) Citation

MA, G., Z, W., J, R., MA, D., F, J., RJ, G., . . . KT, F. (2025). Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H. JCO precision oncology, 9, e2400451. https://doi.org/10.1200/PO-24-00451

Chicago Style (17th ed.) Citation

MA, Gouda, et al. "Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H." JCO Precision Oncology 9 (2025): e2400451. https://doi.org/10.1200/PO-24-00451.

MLA (9th ed.) Citation

MA, Gouda, et al. "Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H." JCO Precision Oncology, vol. 9, 2025, p. e2400451, https://doi.org/10.1200/PO-24-00451.